Bionovo (bnvi) to present positive results from phase 2 trial of Menerba
Bionovo, Inc. announced it will be presenting the positive results from the phase 2 clinical trial of their lead drug candidate for postmenopausal symptoms, Menerba, to the international community at the 8th Annual European Society for Gynecology in Rome, Italy.
Boston Scientific Corporation recently received US Food and Drug Administration approval for its Genesys HTA System for the treatment of menorrhagia.